Day: September 29, 2025

Tokyo, Japan and Cambridge and London, UK, 30 September 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) announces that it has reached a second important R&D milestone under its multi-target discovery collaboration with AbbVie focused on neurological diseases, resulting in a payment of US$10 million to Nxera. Nxera and AbbVie entered this multi-target collaboration in 2022 to leverage Nxera’s NxWave™ platform to discover novel medicines targeting G protein-coupled receptors (GPCRs) associated with neurological disease. This current milestone relates to the identification of validated and differentiated ‘hit’ molecules against a neurology target. Under the terms of the agreement, Nxera is eligible to receive up to US$40 million in near-term research milestones, as well as further potential option, development...

WINDSOR, Ontario, Sept. 29, 2025 (GLOBE NEWSWIRE) — NEXE Innovations Inc. (“NEXE”, the “Company”, “we”, “us” or “our”) (TSX.V: NEXE) (Frankfurt: NX5) (OTC: NEXNF), a compostable and innovative materials company, is pleased to announce its financial results for the twelve-month and three-month period ended May 31, 2025 (“Q4 2025”).NEXE has entered into collaboration with five coffee companies representing more than 15 K-Cup brands. Over 50 SKUs have been developed, with repeat orders delivered to all five partners. Partners have provided positive feedback on NEXE’s fully compostable, patent-protected pod, which is positioned as an alternative to conventional plastic pods. The Company maintains a strong balance sheet, supporting operational scalability and future growth initiatives. Cash position and short-term investments stand...

TORONTO, Sept. 29, 2025 (GLOBE NEWSWIRE) — Carbon Streaming Corporation (Cboe CA: NETZ) (OTCQB: OFSTF) (FSE: M2Q) (“Carbon Streaming” or the “Company”) announces that the conditions have been satisfied to implement the settlement agreement entered into in connection with resolving the dispute between the Company and with Infinite-Earth Limited (“IE”), PT Infinite Earth Nusantara (“PT IE”), certain of IE’s principals and related entities (collectively, the “IE Parties”) related to the Rimba Raya Biodiversity Reserve Project (the “Rimba Raya Project”) previously announced on July 24, 2025. Carbon Streaming has received the payment of US$650,000 from IE and has cancelled 4,539,180 common shares in the capital of Carbon Streaming (“Common Shares”) surrendered by the IE Parties. Following the cancellation of the 4,539,180 Common Shares,...

Treatment remained well-tolerated with consistent injection feasibility in 103 heavily pre-treated patients with R/M-HNSCC naïve or resistant to anti-PD-1 63% (26/41) disease control rate (“DCR”) and 37% (15/41) objective response rate (“ORR”) in evaluable anti-PD-1 naïve patients per RECIST 1.1 74% (37/50) DCR and 32% (16/50) ORR in evaluable anti-PD-1 resistant patients per RECIST 1.1 15.5 months median Overall Survival (“mOS”) in evaluable anti-PD-1 naïve patients 11.4 months mOS in evaluable anti-PD-1 resistant patients Investigators concluded that these promising results warrant further exploration in randomized controlled trialsData presented as a “Top-rated Abstract in Head and Neck Cancer” at the 2025 Annual Meeting of the American Society for Radiation Oncology (ASTRO) on September 29th PARIS and CAMBRIDGE, Mass., Sept. 29,...

TORONTO, Sept. 29, 2025 (GLOBE NEWSWIRE) — Altai Resources Inc. (TSXV: ATI) (“Altai” or the “Company”) announced today that it has sold its ownership of a 50% working interest in the oil wells property located in Cessford, Alberta, comprised of 4 oil wells (the “Cessford Oil Wells Property”), to the owner of the other 50% working interest, and the property’s operator, Canadian Natural Resources Limited (“CNRL”), for a net liability settlement of $50,674 (the “Net Liability Settlement”), which is comprised of the sale of the asset portion and the settlement of the liability portion. The Net Liability Settlement has been paid for by an inter-bank cash transfer from the Company to CNRL. The Net Liability Settlement represents a gain of $111,728 (or approximately 69%) over the Company’s decommissioning liability, net of the carrying...

SARASOTA, Fla., Sept. 29, 2025 (GLOBE NEWSWIRE) — INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics and related businesses and technologies, today announced that it will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2025 Investor Conference, taking place virtually on Tuesday, September 30, 2025. Company Webcast The webcast presentation will take place at 5:00 p.m. ET on Tuesday, September 30, 2025. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/fall2025/ or directly at https://app.webinar.net/arwq56W8612. The webcast will also be available for...